Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999
Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999
Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999
Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998
Fiddleheads and the International Normalized Ratio
NEJM 338:1550, Bartle,W.R.&Ferland,G., 1998
Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998
A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996
Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996
Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
NEJM 333:11-17, 541995., Cannegieter,S.C.,et al, 1995
US National Survey of Physician Practices for the Secondary & Tertiary Prevention of Ischemic Stroke:Common Practices
Stroke 26:1607-1615, Goldstein,L.B.,et al, 1995
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995
Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992
A 62-Year-Old Woman with Progressive Spasticity, Weakness,and Gait Instability
Neurol 104:e210290, Voloshyna-Farber, E.Y.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Palliative and End-of-Life Care in Stroke:A Scientific Statement from the American Heart Association
Stroke 56;e75-e86, Creutzfeldt,C.J.,et al, 2025
Spontaneous Spinal Cord Infarction in a Young Patient: An Overview of Clinical Features and Management
Stroke 56:58-61, Chornay,C.,et al, 2025
A 68-YEar-Old Man with Progressive Numbness, Vertigo, and Cognitive Decline
Neurol 104:e213437, Regan,S.M. & Davalos,L.F., 2025
Polka Dot Intracerebral Hemorrhage in Leukemia
Stroke 56:e49-e50, Rebchuk,A.D.,et al, 2025
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025
A 19-Year-Old Woman with Progressive Weakness and Numbness in Her Arms and Legs
Neurol 104:e213495, Alsabah,A-A.,et al, 2025
A 60-Year-Old Man with Weakness and Gait Dysfunction
JAMA Neurol 82:305-306, Jones,F.J.S.,et al, 2025
Functional Outcome in Patients with Carotid Artery Dissection Undergoing Thrombectomy or Standard Medical Treatment
Neurol 104:e213465, Sykora,M.,et al, 2025
A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Endovascular Therapy for Patients with Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurol 104:e213442, Marto,J.P.,et al, 2025
Congenital Titinopathy:Comprehensive Characterization of the Most Severe End of the Disease Spectrum
Ann Neurol 97:611-628, Coppens,S.,et al, 2025
Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
NEJM 392:1385-1395,1440, Goyal,lM.,et al, 2025
Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
NEJM 392:1374-1384,1440, Psychogios,M.,et al, 2025
Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025
Low Hemoglobin Causes Intracerebral Hemorrhage Outcomes
Stroke 56:1234-1242, Cottarelli,A., et al, 2025
Clinicopathologic Conference, Cryptococcus Neoformans and Cushings Syndrome
NEJM 392:1847-1856, Case 13-2025, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
A 57-Year-Old Man With Chronic Gait Unsteadiness and Diminished Lower Extremity Sensation
Neurol 104:e213713, Rawat,R.,et al, 2025
A 59-Year-Old Man with Progressive Dysarthria and Gait Instability
Neurol 104:e213729, Shen,D.,et al, 2025
A 35-Year-Old Woman with Personality Change and Gait Impairment
Neurol 104:e210252, Bernardes,C.,et al, 2024
Effect of IV Thrombolysis With Alteplase in Patients with Vessel Occlusion in the WAKE-UP Trial
Neurol 104:e209871, Galinovic,I.,et al, 2024
Isolated Primary Central Nervous System Lymphoma of the Optic Nerve, A Case Report and Review of the Literature
Neurologist 29:351-355, Keertana,J.,et al, 2024
Middle Meningeal Artery Embolisation for Nonacute Subdural Hematoma
NEJM 391:1901-1912, Ni,J.L.W.,et al, 2024
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
NEJM 391:1890-1900, Davies,J.M.,et al, 2024
A 50-Year-Old Man with Ataxia, Dystonia, and Abnormal Ocular Movements
Neurol 103:e210046, Panigrahi,B.,et al, 2024
Reversible Cerebral Atrophy and Substantia Nigra Changes after Vitamin B12 Treatment in Infantile Tremor Syndrome
Neurol 103:e210076, Singh,R.,et al, 2024
A 63-Year-Old Man With Progressive Multicranial Neuropathy and Leptomeningeal Enhancement
Neurol 103:e210100, Taga,A.,et al, 2024